Soy moderately improves microstructural properties without affecting bone mass in an ovariectomized rat model of osteoporosis

Bone

Volumn 38, Issue 5, 2006, Pages 686-693

  Devareddy, Latha ^a   Khalil, Dania A ^a   Smith, Brenda J ^a   Lucas, Edralin A ^a   Soung, Do Y ^a   Marlow, Denver D ^a   Arjmandi, Bahram H ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Estrogen; Isoflavones; Microcomputed tomography

Indexed keywords

CASEIN; ESTRADIOL; ISOFLAVONE; SOYBEAN PROTEIN;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; BONE MINERAL; BONE STRUCTURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DUAL ENERGY X RAY ABSORPTIOMETRY; EXAMINATION; FEEDING; FEMALE; FUNCTIONAL ASSESSMENT; LUMBAR VERTEBRA; MICROCOMPUTER; NONHUMAN; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; OVARIECTOMY; PROTEIN CONTENT; PROTEIN DEPLETION; PROTEIN DIET; PROTEIN PURIFICATION; RAT; THICKNESS; TIBIA; TRABECULAR BONE;

ANIMALS; BODY WEIGHT; BONE DENSITY; DENSITOMETRY, X-RAY; DISEASE MODELS, ANIMAL; FEMALE; ISOFLAVONES; LUMBAR VERTEBRAE; ORGAN SIZE; OSTEOPOROSIS; OVARIECTOMY; PLACEBOS; RATS; RATS, SPRAGUE-DAWLEY; SOYBEAN PROTEINS; SOYBEANS; TIBIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646092542     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.10.024     Document Type: Article

References (63)

1. Cosman F., and Lindsay R. Selective estrogen receptor modulators: clinical spectrum. Endocr. Rev. 20 (1999) 418-434
2. Setchell K.D.R. Soy isoflavones-Benefits and risks from nature's selective estrogen receptor modulator (SERMs). J. Am. Coll. Nutr. 20 (2001) 354S-362S
3. Brezinski A., and Debi A. Phytoestrogens: the "natural" selective estrogen receptor modulators. Eur. J. Obstet. Gynecol. Reprod. Biol. 85 (1999) 47-51
4. Potter S.M., Baum J.A., Teng H., Stillman R.J., Shay N.F., and Erdman J.W.J. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women. Am. J. Clin. Nutr. 68 (1998) 1375S-1379S (Suppl)
5. Dalais F.S., Rice G.E., Wahlqvist M.L., Grehan M., Murkies A.L., Medley G., et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric 1 (1998) 124-129
6. Ho S.C., Chan S.G., Yi Q., Wong E., and Leung P.C. Soy intake and the maintenance of peak bone mass in Hong Kong Chinese women. J. Bone Miner. Res. 16 (2001) 1363-1369
7. Gallagher J.C., Rafferty K., Haynatzka V., and Wilson M. Effects of soy protein on bone metabolism. J. Nutr. 130 (2000) 667S
8. Arjmandi B.H., Alekel L., Hollis B.W., Amin D., Stacewica-Sapuntzakis M., and Gou P. Dietary soy protein prevents bone loss in an ovariectomized rat model of osteoporosis. J. Nutr. 126 (1996) 161-167
9. Arjmandi B.H., Birnbaum R., Goyal N.V., Getlinger M.J., Juma S., Alekel L., et al. Bone-sparing effect of soy protein in ovarian hormone deficient rats is related to its isoflavone content. Am. J. Clin. Nutr. 68 (1998) 1364S-1368S
10. Picherit C., Chanteranne B., Bennetau-Pelissero C., Davicco M.J., Lebecque P., Barlet J.P., et al. Dose-dependent bone-sparing effects of dietary isoflavones in the ovariectomized rat. Br. J. Nutr. 85 (2001) 307-316
11. Kanis J.A. Estrogens, the menopause, and osteoporosis. Bone 19 (1996) 185S-190S
12. Judd H.L., Meldrum D.R., Deftos L.J., and Henderson B.E. Estrogen replacement therapy: indications and complications. Ann. Intern. Med. 98 (1983) 195-205
13. Pattijn V., Van Cleynenbreugel T., Vander S.J., Van Audekercke R., Van der P.G., and Wevers M. Structural and radiological parameters for the nondestructive characterization of trabecular bone. Ann. Biomed. Eng. 29 (2001) 1064-1073
14. Sarkar S., Reginster J.Y., Crans G.G., Diez-Perez A., Pinette K.V., and Delmas P.D. Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk. J. Bone Miner. Res. 19 (2004) 394-401
15. Cummings S.R., Bates D., and Black D. Clinical use of bone densitometry: scientific review. JAMA 288 (2002) 1889-1897
16. Kinney J.H., Lane N.E., and Haupt D.L. In vivo, three-dimensional microscopy of trabecular bone. J. Bone Miner. Res. 10 (1995) 264-270
17. Mawatari T., Miura H., Higaki H., Kurata K., Moro-oka T., Murakami T., et al. Quantitative analysis of three-dimensional complexity and connectivity changes in trabecular microarchitecture in relation to aging, menopause, and inflammation. J. Orthop. Sci. 4 (1999) 431-438
18. Arjmandi B.H., Lucas E.A., Juma S., Soliman A., Stoecker B.J., Khalil D.A., et al. Dried plums prevent ovariectomy-induced bone loss in rats. JANA 4 (2001) 50-56
19. Gowen M., Lazner F., Dodds R., Kapadia R., Field J., Tavaria M., et al. Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J. Bone Miner. Res. 14 (1999) 1654-1663
20. Arjmandi B.H., Khan D.A., Juma S.S., and Svanborg A.S. The ovarian hormone deficiency-induced hypercholesterolemia is reversed by soy protein and the synthetic isoflavone, ipriflavone. Nutr. Res. 17 (1997) 885-894
21. Dang Z.C., van Bezooijen R.L., Karperien M., Papapoulos S.E., and Lowik C.W. Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner. Res. 17 (2002) 394-405
22. Blum S.C., Heaton S.N., Bowman bM., Hegsted M., and Miller S.C. Dietary soy protein maintains some indices of bone mineral density and bone formation in aged ovariectomized rats. J. Nutr. 133 (2003) 1244-1249
23. Tchernof A., and Poehlman E.T. Effects of the menopause transition on body fatness and body fat distribution. Obes. Res. 6 (1998) 246-254
24. Joyner J.M., Hutley L.J., and Cameron D.P. Estrogen receptors in human preadipocytes. Endocrine 15 (2001) 225-230
25. de la Brousse F.C., Shan B., and Chen J.L. Identification of the promoter of the mouse obese gene. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 4096-4101
26. Sohn E., Deyhim F., Devareddy L., and Arjmandi B.H. Soy isoflavones attenuate estrogen deficiency-induced increases in abdominal fat in the hamster. Nutr. Res. 24 (2004) 1023-1029
27. Arjmandi B.H., Getlinger M.J., Goyal N.V., Alekel L., Hasler C.M., Juma S., et al. The role of soy protein with normal or reduced isoflavone content in reversing bone loss induced by ovarian hormone deficiency in rats. Am. J. Clin. Nutr. 68 (1998) 1358S-1363S
28. Kalu D.N., Liu C.C., Hardin R.R., and Hollis B.W. The aged rat model of ovarian hormone deficiency bone loss. Endocrinology 126 (1989) 7-16
29. Phipps W.R., Wangen K.E., Duncan A.M., Merz-Demlow B.E., Xu X., and Kurzer M.S. Lack of effect of isoflavonic phytoestrogen intake on leptin concentrations in premenopausal and postmenopausal women. Fertil. Steril. 75 (2001) 1059-1064
30. Barengolts E.I., Kouznetsova T., Segalene A., Lathon P., Odvina C., Kukreja S.C., et al. Effects of progesterone on serum levels of IGF-1 and on femur IGF-1 mRNA in ovariectomized rats. J. Bone Miner. Res. 11 (1996) 1406-1412
31. Kalu D.N., Arjmandi B.H., Liu C., Salih M.A., and Birnbaum R.S. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner. 25 (1994) 135-148
32. Picherit C., Bennetau-Pelissero C., Chanteranne B., Labecque P., Davicco M.J., Barlet J.P., et al. Soybean isoflavones dose-dependently reduce bone turnover but do not reverse established osteopenia in adult ovariectomized rats. J. Nutr. 131 (2001) 723-728
33. Arjmandi B.H., Lucas E.A., Khalil D.A., Devareddy L., Smith B.J., McDonald J., et al. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women. J. Nutr. 4 (2005) 8
34. Nakai M., Cook L., Pyter L.M., Black M., Sibona J., Turner R.T., et al. Dietary soy protein and isoflavones have no significant effect on bone and a potentially negative effect on the uterus of sexually mature intact Sprague-Dawley female rats. Menopause 12 (2005) 291-298
35. Nakai M., Black M., Jeffery E.H., and Bahr J.M. Dietary soy protein and isoflavones: no effect on the reproductive tract and minimal positive effect on bone resorption in the intact female Fischer 344 rat. Food Chem. Toxicol. 43 (2005) 945-949
36. Cai D.J., Zhao Y., Glasier J., Cullen D., Barnes S., Turner C.H., et al. Comparative effect of soy protein, soy isoflavones, and 17beta-estradiol on bone metabolism in adult ovariectomized rats. J. Bone Miner. Res. 20 (2005) 828-839
37. Bahr J.M., Nakai M., Rivera A., Walsh J., Evans G.L., Lotinun S., et al. Dietary soy protein and isoflavones: minimal beneficial effects on bone and no effect on the reproductive tract of sexually mature ovariectomized Sprague-Dawley rats. Menopause 12 (2005) 165-173
38. Atkinson C., Compston J.E., Day N.E., Dowsett M., and Bingham S.A. The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial. Am. J. Clin. Nutr. 79 (2004) 326-333
39. Chen Y.M., Ho S.C., Lam S.S., Ho S.S., and Woo J.L. Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J. Clin. Endocrinol. Metab. 88 (2003) 4740-4747
40. Alekel D.L., St Germain A., Peterson C.T., Hanson K.B., Stewart J.W., and Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 72 (2000) 679-680
41. Bouxsein M.L. Mechanisms of osteoporosis therapy: a bone strength perspective. Clin. Cornerstone Suppl. 2 (2003) S13-S21
42. Borah B., Dufresne T.E., Chmielewski P.A., Gross G.J., Prenger M.C., and Phipps R.J. Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J. Bone Miner. Res. 17 (2002) 1139-1147
43. Ulrich D., van Rietbergen B., Laib A., and Ruegsegger P. The ability of three-dimensional structural indices to reflect mechanical aspects of trabecular bone. Bone 25 (1999) 55-60
44. Muller R., Hannan M., Smith S.Y., and Bauss F. Intermittent ibandronate preserves bone quality and bone strength in the lumbar spine after 16 months of treatment in the ovariectomized cynomolgus monkey. J. Bone Miner. Res. 19 (2004) 1787-1796
45. Lane N.E., Kumer J.L., Majumdar S., Khan M., Lotz J., Stevens R.E., et al. The effects of synthetic conjugated estrogens, a (cenestin) on trabecular bone structure and strength in the ovariectomized rat model. Osteoporos. Int. 13 (2002) 816-823
46. Wronski T.J., Dann L.M., Scott K.S., and Cintrón M. Long-term effects of ovariectomy and aging on the rat skeleton. Calcif. Tissue Int. 45 (1989) 360-366
47. Alexander J.M., Bab I., Fish S., Muller R., Uchiyama T., Gronowica G., et al. Human arathyroid hormone 1-34 reverses bone loss in ovariectomized mice. J. Bone Miner. Res. 16 (2001) 1665-1673
48. Lark M.W., Stroup G.B., James I.E., Dodds R.A., Hwang S.M., Blake S.M., et al. A potent small molecule, nonpeptide inhibitor of Cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30 (2002) 746-753
49. Lark M.W., Stroup G.B., Dodds R.A., Kapadia R., Hoffman S.J., Hwang S.M., et al. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Miner. Res. 16 (2001) 319-327
50. Laib A., Kumer J.L., Majumdar S., and Lane N.E. The temporal changes of trabecular architecture in ovariectomized rats assessed by MicroCT. Osteoporos. Int. 12 (2001) 936-941
51. Seeman E. Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos. Int. 14 Suppl. 3 (2003) S2-S8
52. Barger-Lux M.J., and Recker R.R. Bone microstructure in osteoporosis: transilial biopsy and histomorphometry. Top. Magn. Reson. Imaging 13 (2002) 297-305
53. Kinney J.H., Haupt D.L., Balooch M., Ladd A.J.C., Ryaby J.T., and Lane N.E. Three-dimensional morphometry of the L6 vertebra in the ovariectomized rat model of osteoporosis: biomechanical implications. J. Bone Miner. Res. 15 (2000) 1981-1991
54. Fanti O., Monier-Faugere M.C., Geng Z., Schmidt J., Morris P.E., Cohen D., et al. The phytoestrogen genistein reduces bone loss in short-term overiectomized rats. Osteoporos. Int. 8 (1998) 274-281
55. Choi E.M., Suh K.S., Kim Y.S., Choue R.W., and Koo S.J. Soybean ethanol extract increases the function of osteoblastic MC3T3-E1 cells. Phytochemistry 56 (2001) 733-739
56. Lee Y.S., Chen X., and Anderson J.J.B. Physiological concentrations of genistein stimulate the proliferation and protect against free radical-induced oxidative damage of MC3T3-E1 osteoblast-like cells. Nutr. Res. 21 (2001) 1287-1298
57. Sugimoto T., Nishiyama K., Kuribayashi F., and Chihara K. Serum levels of insulin-like growth factor (IGF) 1, IGF-binding protein (IGFBP) -2, and IGFBP-3 in osteoporotic patients with and without spinal fractures. J. Bone Miner. Res. 12 (1997) 1272-1279
58. Devareddy L., Soung D., Khalil D.A., Lucas E.A., Smith B.J., Arquitt A.B., et al. Soy isoflavones may increase bone formation as seen by enhanced osteoblast-specific gene products in ovariectomized rat model of postmenopausal osteoporosis. J. Bone Miner. Res. (2004) S218
59. Gao Y.H., and Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: involvement of protein kinase inhibition and protein tyrosine phosphatase activation. Int. J. Mol. Med. 5 (2000) 261-267
60. Gao Y.H., and Yamaguchi M. Suppressive effect of genistein on rat bone osteoclasts: apoptosis is induced through Ca2+ signaling. Biol. Pharm. Bull. 22 (1999) 805-809
61. Amano H., Yamada S., and Felix R. Colony-stimulating factor-1 stimulates the fusion process in osteoclasts. J. Bone Miner. Res. 13 (1998) 846-853
62. Arjmandi B.H., Khalil D.A., Smith B.J., Lucas E.A., Juma S., Payton M.E., et al. Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion. J. Clin. Endocrinol. Metab. 88 (2003) 1048-1054
63. Weaver C.M., and Cheong J.M. Soy isoflavones and bone health: the relationship is still unclear. J. Nutr. 135 5 (2005) 1243-1247